P. Chamouni

发表

Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): study protocol for a multicentric French national observational cross-sectional study

K. Baumstarck, P. Auquier, T. Lambert, 2018, BMJ Open.

Management of von Willebrand disease with a factor VIII‐poor von Willebrand factor concentrate: Results from a prospective observational post‐marketing study

S. Susen, A. Harroche, A. Borel‐Derlon, 2020, Journal of thrombosis and haemostasis : JTH.

Adverse effect of polyvalent immunoglobulin in the treatment of Guillain-Barre syndrome.

P. Chamouni, P. Czernichow, C. Girault, 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Assessment of prolonged hospital stay attributable to surgical site infections using appropriateness evaluation protocol.

P. Chamouni, V. Merle, J. Germain, 2000, American journal of infection control.

Prostate biopsy and prostate cancer management in patients with haemophilia: The experience of French Haemophilia Treatment Centres

C. Biron-Andréani, S. Castet, P. Chamouni, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Double relapse of incomplete form of thrombotic thrombocytopenic purpura.

P. Chamouni, P. Czernichow, C. Girault, 2003, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

First observation of inhibitor development against efmoroctocog alfa in France.

C. Königs, P. Chamouni, P. Billoir, 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

The Hemarthrosis-Simulating Knee Model: A Useful Tool for Individualized Education in Patients with Hemophilia (GEFACET Study)

P. Chamouni, E. de Raucourt, B. Frotscher, 2021, Journal of blood medicine.

Revised terminal half‐life of nonacog alfa as derived from extended sampling data: A real‐world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis

T. Lambert, A. Harroche, L. Ardillon, 2022, Haemophilia : the official journal of the World Federation of Hemophilia.

Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?

A. Harroche, C. Berger, P. Chamouni, 2020, Pharmaceutics.

Management of patients with inherited bleeding disorders in oral surgery: a 13-year experience.

P. Chamouni, V. Barbay, O. Trost, 2022, Journal of stomatology, oral and maxillofacial surgery.

Effectiveness of long‐term prophylaxis using pdFVIII/VWF concentrate in patients with inherited von Willebrand disease

A. Harroche, P. Chamouni, D. Desprez, 2022, European journal of haematology.

Gastrointestinal bleeding from angiodysplasia in von Willebrand disease: Improved diagnosis and outcome prediction using videocapsule on top of conventional endoscopy

S. Susen, A. Harroche, C. Berger, 2020, Journal of thrombosis and haemostasis : JTH.

[Transfusions of rhesus-incompatible platelet concentrates in Rouen University Hospital: procedures and consequences].

P. Chamouni, M. Tavolacci, P. Czernichow, 2005, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

Transient anti rhesus alloantibody produced by graft after non-myeloablative allogeneic stem cell transplant.

H. Tilly, P. Chamouni, N. Contentin, 2004, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Factor XII deficiency evaluated by thrombin generation assay.

P. Chamouni, P. Billoir, V. Barbay, 2021, Clinical biochemistry.

Difficulties in the management of an incomplete form of refractory thrombotic thrombocytopenic purpura, the usefulness of vincristine.

P. Chamouni, A. Boyer, V. Merle, 2000, Transfusion science.

Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study

P. Chamouni, E. de Raucourt, J. Goudemand, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis

A. Harroche, C. Biron-Andréani, P. Chamouni, 2022, Thrombosis and Haemostasis.

Afibrinogenemia with two compound heterozygous mutations in FGA gene

P. Chamouni, A. Casini, M. Neerman-Arbez, 2021, Haemophilia.

Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort

M. Boucekine, A. Harroche, Vanessa Milien, 2020, British journal of haematology.

Determinants of adherence and consequences of the transition from adolescence to adulthood among young people with severe haemophilia (TRANSHEMO): A multicentric French national observational cross‐sectional study based on the FranceCoag registry

K. Baumstarck, P. Auquier, M. Boucekine, 2023, Haemophilia : the official journal of the World Federation of Hemophilia.

Abnormal bleeding phenotype for mild haemophilia B patients with the p.Ile112Thr variation on the gene for factor IX

C. Berger, P. Chamouni, A. Lienhart, 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

Surgery in rare bleeding disorders: the prospective MARACHI study

C. Biron-Andréani, A. Borel‐Derlon, S. Castet, 2023, Research and practice in thrombosis and haemostasis.